United States · FDA National Drug Code directory
ARANESP
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55513-021_2f0f60a5-832a-4954-ba26-7dec84fcf4f3
- Product NDC
- 55513-021
- Form
- INJECTION, SOLUTION
- Composition / generic term
- darbepoetin alfa
- Labeler
- Amgen, Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20060814
- Source listing expiry
- 20271231
Source-listed ingredients
- DARBEPOETIN ALFA — 40 ug/.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 PACKAGE (55513-021-04) / 4 SYRINGE in 1 BLISTER PACK / .4 mL in 1 SYRINGE (55513-021-01) · 55513-021-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →